About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Phoenix | 100 Studies

Clinical Trials EpilepsyPhoenix

Epilepsy Clinical Trials in Phoenix

Find 100 clinical trials for epilepsy near Phoenix, Arizona. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 100 trials

CompletedA Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresThis is a multicenter, double-blind, randomized, placebo-controlled dose response study, with an 8-week prospective baseline and an 18 week double-blind treatment period…NCT01866111·Phoenix, Arizona and 66 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

WithdrawnGW273225 Therapy Added To Current Seizure Treatments In Patients With Partial SeizuresStudy to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoinNCT00567424·Phoenix, Arizona and 29 others

CompletedEvaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial SeizuresEvaluation of the safety and efficacy of Oxcarbazepine XR as adjunctive treatment for adults with partial onset seizuresNCT00772603·Huntsville, Alabama and 70 others

CompletedStudy to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset SeizuresThe purpose of this study is to examine the safety and effectiveness of USL255 as adjunctive therapy in patients with refractory partial onset-seizures.NCT01142193·Phoenix, Arizona and 68 others

CompletedLong-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset SeizuresTo allow pediatric patients with partial onset seizures an opportunity to receive (as follow-up to studies N01009(NCT00105040)/N01103(NCT00175890) or by direct enrollment)…NCT00152516·Mobile, Alabama and 83 others

CompletedDose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset SeizuresThe primary objective of this study is to assess the pharmacokinetics of cenobamate (YKP3089) in pediatric subjects with partial-onset (focal) seizures following single and…NCT04903314·Phoenix, Arizona and 12 others

RecruitingEpilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)Concurrent electroencephalography (EEG) and new tripolar EEG (tEEG) will be recorded from adult and pediatric patients.NCT05944692·Phoenix, Arizona and 1 other

CompletedOpen-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset SeizuresThe study will evaluate the long-term safety and tolerability of pregabalin in pediatric patients, age 1 month through 16 years, with partial onset seizures.NCT00448916·Mobile, Alabama and 17 others

TerminatedA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresAntiepileptic drugs (AEDs) are the main treatment for epilepsy; however, only a limited number of AEDs are approved for use as monotherapy.NCT00698581·Phoenix, Arizona and 52 others

CompletedA Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.This trial will evaluate the efficacy and safety of brivaracetam (at doses of 5, 20 and 50 mg/day in twice a day administration) as add-on therapy in subjects with focal epilepsy.NCT00175825·Phoenix, Arizona and 41 others

Enrolling by invitationElectrochemical and Electrophysiological StudyThis study will utilize computerized algorithms in combination with real-time intracranial neurophysiological and neurochemical recordings and microstimulation to measure…NCT05273970·Phoenix, Arizona

Active not recruitingA Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.NCT06132893·Phoenix, Arizona and 103 others

CompletedLamotrigine Extended-Release In Elderly Patients With EpilepsyThis study is being conducted to determine the safety and tolerability of lamotrigine (LTG) in elderly patients with epilepsy.NCT00516139·Birmingham, Alabama and 62 others

CompletedTo Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial SeizuresTo evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.NCT00141388·Birmingham, Alabama and 55 others

CompletedA Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset SeizuresThis study evaluated the efficacy and safety of two trough-ranges of everolimus given as adjunctive therapy in patients with tuberous sclerosis complex (TSC) who had refractory…NCT01713946·Birmingham, Alabama and 103 others

CompletedStudy of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency DisorderA clinical study to evaluate the efficacy, safety, and tolerability of adjunctive ganaxolone therapy compared to placebo for the treatment of seizures in children and young adults…NCT03572933·Phoenix, Arizona and 35 others

CompletedPivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal EpilepsyThis is a multiple site, randomized, double blinded parallel-group controlled study.NCT04770337·Phoenix, Arizona and 31 others

CompletedBrivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresThis study will evaluate the efficacy and safety of brivaracetam at doses of 100 and 200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with…NCT01261325·Phoenix, Arizona and 206 others

CompletedConversion to Monotherapy Study With Keppra XR for Partial SeizuresThe primary objective of this study is to assess the efficacy of two doses of Keppra XR compared with a historical control as the placebo, in the monotherapy treatment of partial…NCT00419094·Dothan, Alabama and 44 others

CompletedTrial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset SeizuresThe objective of this historical-controlled trial is to demonstrate the efficacy and safety of conversion to Lacosamide monotherapy in subjects with Partial-onset Seizures who are…NCT00520741·Alabaster, Alabama and 157 others

PreviousPage 2 of 5Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia